Cargando…

A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors

The COVID-19, caused by SARS-CoV-2, is threatening public health, and there is no effective treatment. In this study, we have implemented a multi-targeted anti-viral drug design strategy to discover highly potent SARS-CoV-2 inhibitors, which simultaneously act on the host ribosome, viral RNA as well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Peng-xuan, Shang, Wei-juan, Yin, Wan-chao, Ge, Huan, Wang, Lin, Zhang, Xiang-lei, Li, Bing-qian, Li, Hong-lin, Xu, Ye-chun, Xu, Eric H., Jiang, Hua-liang, Zhu, Li-li, Zhang, Lei-ke, Bai, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076879/ https://www.ncbi.nlm.nih.gov/pubmed/33907306 http://dx.doi.org/10.1038/s41401-021-00668-7

Ejemplares similares

Characterization of a Self-renewing and Multi-potent Cell Population Isolated from Human Minor Salivary Glands
por: Lu, Lin, et al.
Publicado: (2015)

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
por: Li, Zhe, et al.
Publicado: (2020)

Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers
por: Xu, Jiaxuan, et al.
Publicado: (2023)

Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2022)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
por: Fan, Wenli, et al.
Publicado: (2021)

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019)

Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents
por: Li, Bing-Hui, et al.
Publicado: (2021)

Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors
por: Zhang, Yuejuan, et al.
Publicado: (2022)

Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy
por: Xu, Menglong, et al.
Publicado: (2021)

Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
por: Wang, Lin, et al.
Publicado: (2021)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
por: Chen, Yiming, et al.
Publicado: (2021)

Synthetic Routes and Biological Evaluation of Largazole and Its Analogues as Potent Histone Deacetylase Inhibitors
por: Li, Shang, et al.
Publicado: (2011)

Discovery of 2-(4-Acrylamidophenyl)-Quinoline-4-Carboxylic Acid Derivatives as Potent SIRT3 Inhibitors
por: Hui, Qian, et al.
Publicado: (2022)

iOPTICS-GSO for identifying protein complexes from dynamic PPI networks
por: Lei, Xiujuan, et al.
Publicado: (2017)

Nanodiamond-supported silver nanoparticles as potent and safe antibacterial agents
por: Chang, Be-Ming, et al.
Publicado: (2019)

Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
por: Zhang, Lihui, et al.
Publicado: (2019)

In situ orderly self-assembly strategy affording NIR-II-J-aggregates for in vivo imaging and surgical navigation
por: Li, Zhe, et al.
Publicado: (2023)

A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity
por: Li, Xiao, et al.
Publicado: (2023)

Cross-species metabolomic analysis identifies uridine as a potent regeneration promoting factor
por: Liu, Zunpeng, et al.
Publicado: (2022)

Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides
por: Shao, Huili, et al.
Publicado: (2021)

Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
por: Zhao, Hongying, et al.
Publicado: (2022)

Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
por: Huang, Fangmin, et al.
Publicado: (2023)

Potent Inhibition of Human Cytochrome P450 3A4 by Biflavone Components from Ginkgo Biloba and Selaginella Tamariscina
por: Wang, Bo, et al.
Publicado: (2022)

Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients
por: Luo, Xinle, et al.
Publicado: (2020)

Three-dimensional convolutional neural network model to identify clinically significant prostate cancer in transrectal ultrasound videos: a prospective, multi-institutional, diagnostic study
por: Sun, Yi-Kang, et al.
Publicado: (2023)

Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
por: Li, Xin, et al.
Publicado: (2017)

Readout-segmented echo-planar diffusion-weighted MR for the evaluation of aggressive characteristics of rectal cancer
por: Xia, Chun-chao, et al.
Publicado: (2018)

Multi-bacillary leprosy under the Chinese leprosy elimination program()
por: Li, Ge, et al.
Publicado: (2022)

Deciphering chloramphenicol biotransformation mechanisms and microbial interactions via integrated multi-omics and cultivation-dependent approaches
por: Zhang, Jiayu, et al.
Publicado: (2022)

25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor
por: Zu, Shulong, et al.
Publicado: (2020)

Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase
por: Qiu, Yan, et al.
Publicado: (2016)

Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
por: Shan, Hengyue, et al.
Publicado: (2021)

SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer
por: Yan, Ruorong, et al.
Publicado: (2015)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

Identifying disease-associated signaling pathways through a novel effector gene analysis
por: Bao, Zhenshen, et al.
Publicado: (2020)

Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
por: Lu, Lei, et al.
Publicado: (2014)

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
por: Gao, Min, et al.
Publicado: (2010)

Neoadjuvant treatment strategies for hepatocellular carcinoma
por: Xu, Lei, et al.
Publicado: (2021)

A new sequential two-stent strategy for treating true distal left main trifurcation lesion
por: DAI, Yu-Xiang, et al.
Publicado: (2021)

FindIT2: an R/Bioconductor package to identify influential transcription factor and targets based on multi-omics data
por: Shang, Guan-Dong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5299us8ak6jpg2sl1dvbrork2